Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS
· Delayed Price · Currency is USD
0.4899
+0.0499 (11.33%)
Apr 24, 2025, 12:49 PM EDT
Pharma-Bio Serv Balance Sheet
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 7.31 | 6.77 | 10.45 | 14.46 | 17.47 | 17.14 | Upgrade
|
Short-Term Investments | 5.13 | 5.98 | 4.53 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 12.43 | 12.75 | 14.98 | 14.46 | 17.47 | 17.14 | Upgrade
|
Cash Growth | -21.74% | -14.90% | 3.56% | -17.21% | 1.93% | 10.64% | Upgrade
|
Accounts Receivable | 2.68 | 2.51 | 3.94 | 4.98 | 4.61 | 9.73 | Upgrade
|
Receivables | 2.68 | 2.51 | 3.94 | 4.98 | 4.61 | 10.98 | Upgrade
|
Prepaid Expenses | 0.42 | 0.44 | 0.48 | 0.5 | 0.74 | 0.47 | Upgrade
|
Total Current Assets | 15.53 | 15.7 | 19.4 | 19.94 | 22.82 | 28.58 | Upgrade
|
Property, Plant & Equipment | 0.32 | 0.37 | 0.39 | 0.58 | 0.75 | 1.06 | Upgrade
|
Other Long-Term Assets | 0.23 | 0.23 | 0.11 | 0.13 | 0.35 | 0.27 | Upgrade
|
Total Assets | 16.08 | 16.29 | 19.9 | 20.65 | 23.92 | 29.92 | Upgrade
|
Accounts Payable | 0.95 | 1.13 | 1.47 | 1.63 | 2.09 | 1.95 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | - | 1.29 | Upgrade
|
Current Portion of Leases | 0.15 | 0.17 | 0.15 | 0.14 | 0.13 | 0.16 | Upgrade
|
Current Income Taxes Payable | 0.6 | 0.59 | 0.53 | 0.34 | 0.45 | 0.39 | Upgrade
|
Other Current Liabilities | 1.72 | - | - | - | - | - | Upgrade
|
Total Current Liabilities | 3.42 | 1.89 | 2.15 | 2.11 | 2.67 | 3.79 | Upgrade
|
Long-Term Debt | - | - | - | - | - | 0.64 | Upgrade
|
Long-Term Leases | - | 0.03 | 0.19 | 0.35 | 0.49 | 0.63 | Upgrade
|
Other Long-Term Liabilities | 0.66 | 0.66 | 1.43 | 1.64 | 1.85 | 2.14 | Upgrade
|
Total Liabilities | 4.08 | 2.58 | 3.78 | 4.09 | 5.01 | 7.2 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 1.66 | 1.64 | 1.6 | 1.55 | 1.48 | 1.42 | Upgrade
|
Retained Earnings | 10.64 | 12.35 | 14.85 | 15.27 | 17.71 | 21.52 | Upgrade
|
Treasury Stock | -0.55 | -0.55 | -0.54 | -0.5 | -0.42 | -0.39 | Upgrade
|
Comprehensive Income & Other | 0.24 | 0.26 | 0.21 | 0.24 | 0.14 | 0.16 | Upgrade
|
Shareholders' Equity | 12 | 13.72 | 16.13 | 16.56 | 18.91 | 22.72 | Upgrade
|
Total Liabilities & Equity | 16.08 | 16.29 | 19.9 | 20.65 | 23.92 | 29.92 | Upgrade
|
Total Debt | 0.15 | 0.19 | 0.35 | 0.49 | 0.62 | 2.72 | Upgrade
|
Net Cash (Debt) | 12.28 | 12.55 | 14.63 | 13.98 | 16.85 | 14.41 | Upgrade
|
Net Cash Growth | -21.18% | -14.21% | 4.69% | -17.07% | 16.91% | -6.48% | Upgrade
|
Net Cash Per Share | 0.53 | 0.55 | 0.64 | 0.61 | 0.73 | 0.63 | Upgrade
|
Filing Date Shares Outstanding | 22.93 | 22.96 | 22.96 | 22.95 | 22.97 | 23.03 | Upgrade
|
Total Common Shares Outstanding | 22.96 | 22.96 | 22.96 | 22.94 | 23 | 23 | Upgrade
|
Working Capital | 12.11 | 13.81 | 17.25 | 17.84 | 20.15 | 24.79 | Upgrade
|
Book Value Per Share | 0.52 | 0.60 | 0.70 | 0.72 | 0.82 | 0.99 | Upgrade
|
Tangible Book Value | 12 | 13.72 | 16.13 | 16.56 | 18.91 | 22.72 | Upgrade
|
Tangible Book Value Per Share | 0.52 | 0.60 | 0.70 | 0.72 | 0.82 | 0.99 | Upgrade
|
Machinery | - | 0.68 | 0.67 | 0.66 | 0.64 | 0.72 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.